Vatalanib (PTK787/ZK 222584) in Combination with FOLFOX4 Versus FOLFOX4 Alone as First-Line Treatment for Colorectal Cancer: Preliminary Results from the CONFIRM-1 Trial

Clinical Colorectal Cancer ◽

10.1016/s1533-0028(11)70162-1 ◽

2005 ◽

Vol 5 (1) ◽

pp. 24-26 ◽

Author(s):

Preeta Tyagi ◽

Edward Chu ◽

Vinay K. Jain

Keyword(s):

Colorectal Cancer ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

TOMOX compared to FOLFOX4 as first-line treatment in patients (pts) with advanced colorectal cancer (ACRC): Preliminary results of a multicenter randomized phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3599 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3599-3599

Author(s):

C. Grávalos ◽

C. García-Girón ◽

A. I. León ◽

A. Salud ◽

B. Esteban ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

Preliminary Results ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Phase II randomized trial on protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian FOCA Study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3617 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3617-3617 ◽

Author(s):

A. Martoni ◽

C. Pinto ◽

F. Di Fabio ◽

G. Lelli ◽

A. L. Gentile ◽

...

Keyword(s):

Colorectal Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

Bi-weekly administration of capecitabine+oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results

European Journal of Cancer Supplements ◽

10.1016/j.ejcsup.2008.06.040 ◽

2008 ◽

Vol 6 (14) ◽

pp. 120

Author(s):

M. Di Bisceglie ◽

G. Di Maggio ◽

F. Giuliani ◽

V. Lorusso ◽

S. Cinieri ◽

...

Keyword(s):

Colorectal Cancer ◽

Advanced Colorectal Cancer ◽

Line Treatment ◽

Weekly Administration ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

Preliminary results of a randomized study of the safety and tolerability of three oxaliplatin-based regimens as first-line treatment for advanced colorectal cancer (CRC) (“Tree” study)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3537 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3537-3537 ◽

Author(s):

L. Welles ◽

H. Hochster ◽

R. Ramanathan ◽

L. Wong ◽

L. Hart ◽

...

Keyword(s):

Colorectal Cancer ◽

Advanced Colorectal Cancer ◽

Randomized Study ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

TOMOX compared to FOLFOX4 as first-line treatment in patients (pts) with advanced colorectal cancer (ACRC): Preliminary results of a multicenter randomized phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3599 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3599-3599

Author(s):

C. Grávalos ◽

C. García-Girón ◽

A. I. León ◽

A. Salud ◽

B. Esteban ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

Preliminary Results ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (5-FU) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase III trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3532 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3532-3532

Author(s):

J. Souglakos ◽

N. Ziras ◽

A. Polyzos ◽

A. Athanasiadis ◽

S. Kakolyris ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

Preliminary results of a randomized phase III trial of the TTD Group comparing capecitabine and oxaliplatin (CapeOx) vs. oxaliplatin and 5-fluorouracil in continuous infusion (5-FU CI) as first line treatment in advanced or metastatic colorectal cancer (CRC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3524 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3524-3524 ◽

Author(s):

J. Sastre ◽

B. Massuti ◽

J. M. Tabernero ◽

M. Chaves ◽

J. J. Reina ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Continuous Infusion ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

6110 POSTER Combination Chemotherapy With Capecitabine (C), Irinotecan (I) Oxaliplatin (O) and Bevacizumab (B) (XELOXIRIA) as First Line Treatment of Metastatic Colorectal Cancer (MCRC) – Preliminary Results of a Phase l-ll Trial

European Journal of Cancer ◽

10.1016/s0959-8049(11)71755-5 ◽

2011 ◽

Vol 47 ◽

pp. S425

Author(s):

S. Bazarbashi ◽

A. Aljubran ◽

H. Soudy ◽

A. Alzahrani ◽

A. Darwish ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Combination Chemotherapy ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

707 PUBLICATION Capecitabine, oxaliplatin and irinotecan combination: a first line treatment for metastasic colorectal cancer, preliminary results of a phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81002-x ◽

2005 ◽

Vol 3 (2) ◽

pp. 200-201

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (5-FU) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase III trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3532 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3532-3532 ◽

Author(s):

J. Souglakos ◽

N. Ziras ◽

A. Polyzos ◽

A. Athanasiadis ◽

S. Kakolyris ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

Preliminary Results ◽

First Line Treatment

Download Full-text